You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

 

27 Results
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: PET 12
Mar 2015
Drug
Feb 2024
Drug
Other Name(s): Matulane®
Dec 2019
Drug
Other Name(s): Caelyx®
Dec 2019
Drug
Other Name(s): Pomalyst®
Aug 2023
Drug
Other Name(s): Iclusig®
Aug 2023
Drug
Other Name(s): Keytruda®
Aug 2023
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Jan 2024
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Oct 2017
Regimen
Cancer Type:
Hematologic, 
Myeloproliferative Neoplasms (MPNs)
Intent: Palliative
May 2019

Pages